Elevance Health (ELV) Accounts Payables (2009 - 2026)

Elevance Health (ELV) has 18 years of Accounts Payables data on file, last reported at $6.2 billion in Q1 2026.

• Accounts Payables for Q1 2026 came in at $6.2 billion, down 12.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.2 billion (down 12.93% YoY), and the FY2025 annual result was $7.3 billion, up 5.7% from the prior year.
• Accounts Payables retreated to $6.2 billion in Q1 2026 per ELV's latest filing, from $7.3 billion in the prior quarter.
• Over five years, Accounts Payables peaked at $7.3 billion in Q4 2025 and troughed at $4.9 billion in Q1 2023.
• A 5-year average of $6.1 billion and a median of $6.0 billion in 2023 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2022 and 2025: Accounts Payables dropped 16.73% in 2022, then advanced 26.35% in 2025.
• A 5-year view of Accounts Payables shows it stood at $5.6 billion in 2022, then advanced by 23.24% to $6.9 billion in 2023, then climbed by 0.25% to $6.9 billion in 2024, then gained by 5.7% to $7.3 billion in 2025, then retreated by 15.2% to $6.2 billion in 2026.
• Business Quant data shows ELV's Accounts Payables at $6.2 billion in Q1 2026, $7.3 billion in Q4 2025, and $6.1 billion in Q3 2025.